Matches in SemOpenAlex for { <https://semopenalex.org/work/W2468725970> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W2468725970 endingPage "24" @default.
- W2468725970 startingPage "13" @default.
- W2468725970 abstract "There has been continued improvement in preventing early biopsy-proved acute rejections and increasing 1-year allograft success rates, and, after some delay, the conditional half-life of grafts. Beneath these impressive achievements are several troubling concerns: unrecognized subclinical rejections; the emergence of acute and chronic humoral rejection; the different effect of certain acute rejections on the development of chronic rejection; the possibility that the current improvements in reducing early acute rejection may not be translated into longer half-life for the graft unless important adjunctive therapy is included. The use of cyclosporine (CSA) has been reshaped by lower dosing, conversion and avoidance protocols, C2 blood level monitoring, availability of generics, and application to non-transplant immunologically-mediated renal diseases. The enigma of chronic allograft nephropathy (CAN) unfortunately still remains, but recent studies on the effects of hypomagnesemia are provocative. The actual cohort of truly long-term renal transplant successes is providing remarkable insights into the way such grafts and their recipients achieve 30-year success. More than half of these patients have experienced early acute rejections (even Banff II and III). Somewhat contrary to expectations, these recipients usually do not have subnormal levels of CD4+ and CD8+ lymphocytes. However, they are typically B cell depleted, a condition that may protect them from late humoral rejection. Future directions will likely lead to the inclusion of important adjunctive agents having secondary anti-proliferative and anti-fibrogenic capabilities. Because chronic injury to renal allografts, as well as the dominant complications of renal transplantation such as cardiovascular disease and skin cancers, are woven together by a common theme of excessive proliferative activity, albeit of different cell types, long-term therapy will be directed at both protecting the allograft and the allograft recipient by incorporating as long-term therapy selected anti-proliferative agents that could include inhibitors of the renin-angiotensin-aldosterone system, statins, sirolimus, mycophenolic acid and leflunomide." @default.
- W2468725970 created "2016-07-22" @default.
- W2468725970 creator A5003948100 @default.
- W2468725970 date "2003-03-01" @default.
- W2468725970 modified "2023-09-23" @default.
- W2468725970 title "Long-term renal transplantation. Recent successes and new problems." @default.
- W2468725970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12773963" @default.
- W2468725970 hasPublicationYear "2003" @default.
- W2468725970 type Work @default.
- W2468725970 sameAs 2468725970 @default.
- W2468725970 citedByCount "0" @default.
- W2468725970 crossrefType "journal-article" @default.
- W2468725970 hasAuthorship W2468725970A5003948100 @default.
- W2468725970 hasConcept C113280763 @default.
- W2468725970 hasConcept C126322002 @default.
- W2468725970 hasConcept C177713679 @default.
- W2468725970 hasConcept C203014093 @default.
- W2468725970 hasConcept C2778653478 @default.
- W2468725970 hasConcept C2779134260 @default.
- W2468725970 hasConcept C2779458710 @default.
- W2468725970 hasConcept C2780303639 @default.
- W2468725970 hasConcept C2911091166 @default.
- W2468725970 hasConcept C71924100 @default.
- W2468725970 hasConceptScore W2468725970C113280763 @default.
- W2468725970 hasConceptScore W2468725970C126322002 @default.
- W2468725970 hasConceptScore W2468725970C177713679 @default.
- W2468725970 hasConceptScore W2468725970C203014093 @default.
- W2468725970 hasConceptScore W2468725970C2778653478 @default.
- W2468725970 hasConceptScore W2468725970C2779134260 @default.
- W2468725970 hasConceptScore W2468725970C2779458710 @default.
- W2468725970 hasConceptScore W2468725970C2780303639 @default.
- W2468725970 hasConceptScore W2468725970C2911091166 @default.
- W2468725970 hasConceptScore W2468725970C71924100 @default.
- W2468725970 hasIssue "1" @default.
- W2468725970 hasLocation W24687259701 @default.
- W2468725970 hasOpenAccess W2468725970 @default.
- W2468725970 hasPrimaryLocation W24687259701 @default.
- W2468725970 hasRelatedWork W1540807578 @default.
- W2468725970 hasRelatedWork W1718748228 @default.
- W2468725970 hasRelatedWork W1966621515 @default.
- W2468725970 hasRelatedWork W2012225890 @default.
- W2468725970 hasRelatedWork W2086357998 @default.
- W2468725970 hasRelatedWork W2132536044 @default.
- W2468725970 hasRelatedWork W2302987379 @default.
- W2468725970 hasRelatedWork W2412727020 @default.
- W2468725970 hasRelatedWork W2607164125 @default.
- W2468725970 hasRelatedWork W3196309182 @default.
- W2468725970 hasVolume "55" @default.
- W2468725970 isParatext "false" @default.
- W2468725970 isRetracted "false" @default.
- W2468725970 magId "2468725970" @default.
- W2468725970 workType "article" @default.